PREVALENCE OF AMPC β-LACTAMASE GENES AMONG CLINICAL ISOLATES OF ENTEROBACTER SPP. FROM SOME IRAQI HOSPITALS.

Journal Title: European Journal of Biomedical and Pharmaceutical Sciences - Year 2017, Vol 4, Issue 4

Abstract

Background: Resistance to broad spectrum β-lactams mediated ESBLs and AmpC β-lactamase enzymes is a rising problem worldwide. Determination of their prevalence is essential to the creation of an effective antibiotics policy and hospital infection control measures. Method: A total of 35 clinical isolates of Enterobacter spp. that were collected from different clinical specimens during the period between October 2015 to January 2016 were studied. Antibiogram profile was done by disc diffusion test (DDT), along with recommended tests for phenotypic detection of ESBLs and AmpC production. Isolates were also screened for their possessions of AmpC β-lactamase-encoding genes by using polymerase chain reaction (PCR) technique. Results: Antibiogram revealed that most Enterobacter spp. isolates were multi-drug resistant with a high resistance to cephalosporins; cephalexin(100%), cefazolin and cefotaxime(94.28%), while Susceptibility to imipenem. was highest(20%) followed by amikacin, pipracilli/tazobactam (22.85%).The phenotypic detection of ESBL and AmpC β-lactamases revealed that 25(71.42%), 29(82.85%) were ESBLs and AmpC β-lactamase producers respectively, in addition to 22(62.85%) of isolates were gave positive results for both ESBL and AmpC β-lactamases production. Detection of AmpC encoding genes revealed that a total of 28(96.55%) of 29 Enterobacter spp. were possessed AmpC genes that encoding for AmpC β-lactamases, with predominance of blaCIT, blaEBC and blaDHA genes, 16(57.14%), 11(39.28%), 8(28.57%) respectively. Conclusions: Phenotypic and genotypic methods for detection of AmpC-β-lactamese-producing Enterobacter spp. revealed that most of these isolates were AmpC β-lactamase producers;29(82.85%) and 28(96.55%) respectively, with predominance of CIT 16(45.71%) followed by 10(28.57%) , 8(22.85%) for EBC and DHA respectively. furthermore, 22(62.85%) of isolates were gave positive results for both ESBL and AmpC β-lactamases production.

Authors and Affiliations

Dr. Saad L. Hamed

Keywords

Related Articles

KNOWLEDGE AND PRACTICE OF UNDERGRADUATE DENTAL STUDENTS AND INTERNS TOWARD PREVENTIVE DENTISTRY IN QASSIM UNIVERSITY

Objectives  General objective: To investigate knowledge and practices towards preventive dentistry among undergraduate dental students and interns in Qassim university.  Specific objectives: 1. To assess the level of k...

A REVIEW ARTICLE ON AYURVEDIC AND MODERN METHOD OF PRESERVATION AND DISSECTION OF DEAD BODY

Mahrishi Sushruta was an ancient surgeon (who was possibly born in 2nd century BC) and he was the author of the book Sushruta Samhita. According to Susruta to become a best physician & surgeon, the dissection of the dead...

Mycobacterium tuberculosis AND ITS RESILIENCE

Drug resistant pathogens today are emerging and spreading more rapidly than in previous decades. These organisms are widespread but also occur increasingly in the community, affecting developed and developing countries,...

CUTANEOUS MANIFESTATIONS IN HIV INFECTION: A CLINICOPATHOLOGICAL STUDY

The first case of Acquired Immunodeficiency Syndrome (AIDS) was reported in Africa. But today India is considered as a new hotbed for this disease. AIDS is caused by a retrovirus human immunodeficiency virus (HIV). Two t...

ASSOCIATION OF ANGIOTENSIN-CONVERTING ENZYME GENE INSERTION/ DELETION POLYMORPHISM WITH INCREASED RISK FOR CHRONIC LYMPHOCYTIC LEUKAEMIA

Background: Angiotensin converting enzyme (ACE) plays an important role in the stimulation bone marrow hematopoietic progenitors and umbilical cord blood cells proliferation and differentiation by converting angiotensino...

Download PDF file
  • EP ID EP628189
  • DOI -
  • Views 156
  • Downloads 0

How To Cite

Dr. Saad L. Hamed (2017). PREVALENCE OF AMPC β-LACTAMASE GENES AMONG CLINICAL ISOLATES OF ENTEROBACTER SPP. FROM SOME IRAQI HOSPITALS.. European Journal of Biomedical and Pharmaceutical Sciences, 4(4), 1-8. https://europub.co.uk/articles/-A-628189